Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.070
-0.080 (-3.72%)
At close: Dec 5, 2025, 4:00 PM EST
2.060
-0.010 (-0.48%)
After-hours: Dec 5, 2025, 7:45 PM EST
Vivos Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 3.09 | 6.26 | 1.64 | 3.52 | 24.03 | 18.21 | Upgrade
|
| Cash & Short-Term Investments | 3.09 | 6.26 | 1.64 | 3.52 | 24.03 | 18.21 | Upgrade
|
| Cash Growth | -51.09% | 281.01% | -53.31% | -85.36% | 31.99% | 3778.96% | Upgrade
|
| Accounts Receivable | 2.13 | 0.43 | 0.2 | 0.46 | 1.72 | 1.43 | Upgrade
|
| Receivables | 2.13 | 0.43 | 0.2 | 0.46 | 1.72 | 1.52 | Upgrade
|
| Prepaid Expenses | 0.57 | 0.78 | 0.62 | 1.45 | 1.58 | 0.67 | Upgrade
|
| Total Current Assets | 5.79 | 7.47 | 2.46 | 5.42 | 27.32 | 20.39 | Upgrade
|
| Property, Plant & Equipment | 9.03 | 4.38 | 4.7 | 4.78 | 2.83 | 0.87 | Upgrade
|
| Goodwill | 8.45 | 2.84 | 2.84 | 2.84 | 2.84 | 2.67 | Upgrade
|
| Other Intangible Assets | 2.17 | 0.37 | 0.42 | 0.3 | 0.34 | 0.27 | Upgrade
|
| Other Long-Term Assets | 0.21 | 0.22 | 0.31 | 0.37 | 0.36 | 0.31 | Upgrade
|
| Total Assets | 25.64 | 15.28 | 10.73 | 13.72 | 33.69 | 25.33 | Upgrade
|
| Accounts Payable | 2.1 | 1.1 | 2.15 | 1.41 | 0.92 | 0.78 | Upgrade
|
| Accrued Expenses | 2.68 | 2.23 | 2.33 | 1.91 | 2.85 | 1.74 | Upgrade
|
| Current Portion of Long-Term Debt | 0.34 | - | - | - | 1.27 | 0.87 | Upgrade
|
| Current Portion of Leases | 0.79 | 0.48 | 0.47 | 0.42 | - | - | Upgrade
|
| Current Unearned Revenue | 0.54 | 0.9 | 2.14 | 2.93 | 2.4 | 2.94 | Upgrade
|
| Other Current Liabilities | 0.99 | 0.27 | 0.2 | 0.15 | 0.07 | 0.02 | Upgrade
|
| Total Current Liabilities | 7.44 | 4.98 | 7.29 | 6.81 | 7.51 | 6.34 | Upgrade
|
| Long-Term Debt | 8.38 | - | - | - | - | 0.42 | Upgrade
|
| Long-Term Leases | 2.99 | 1.04 | 1.52 | 1.99 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 0 | 0.1 | 0.29 | 0.11 | - | - | Upgrade
|
| Other Long-Term Liabilities | 4.3 | 1.22 | 1.22 | - | 0.64 | 0.15 | Upgrade
|
| Total Liabilities | 23.11 | 7.33 | 10.32 | 8.92 | 8.15 | 6.91 | Upgrade
|
| Common Stock | 0 | - | - | - | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 121 | 112.14 | 93.46 | 84.27 | 81.16 | 52.25 | Upgrade
|
| Retained Earnings | -118.46 | -104.19 | -93.05 | -79.47 | -55.62 | -35.34 | Upgrade
|
| Total Common Equity | 2.53 | 7.95 | 0.41 | 4.8 | 25.54 | 16.92 | Upgrade
|
| Shareholders' Equity | 2.53 | 7.95 | 0.41 | 4.8 | 25.54 | 18.42 | Upgrade
|
| Total Liabilities & Equity | 25.64 | 15.28 | 10.73 | 13.72 | 33.69 | 25.33 | Upgrade
|
| Total Debt | 12.5 | 1.51 | 2 | 2.41 | 1.27 | 1.29 | Upgrade
|
| Net Cash (Debt) | -9.41 | 4.75 | -0.35 | 1.11 | 22.77 | 16.92 | Upgrade
|
| Net Cash Growth | - | - | - | -95.14% | 34.58% | - | Upgrade
|
| Net Cash Per Share | -1.05 | 0.95 | -0.29 | 1.20 | 26.80 | 32.86 | Upgrade
|
| Filing Date Shares Outstanding | 8.99 | 5.89 | 2.73 | 1.19 | 0.92 | 0.73 | Upgrade
|
| Total Common Shares Outstanding | 8.27 | 5.89 | 1.83 | 0.92 | 0.92 | 0.73 | Upgrade
|
| Working Capital | -1.65 | 2.5 | -4.83 | -1.39 | 19.82 | 14.05 | Upgrade
|
| Book Value Per Share | 0.31 | 1.35 | 0.22 | 5.22 | 27.75 | 23.23 | Upgrade
|
| Tangible Book Value | -8.09 | 4.74 | -2.85 | 1.66 | 22.36 | 13.98 | Upgrade
|
| Tangible Book Value Per Share | -0.98 | 0.80 | -1.56 | 1.80 | 24.29 | 19.19 | Upgrade
|
| Machinery | 5.65 | 1.87 | 1.73 | 1.41 | 1.47 | 1.01 | Upgrade
|
| Construction In Progress | - | 1.86 | 1.44 | 0.95 | 0.21 | 0.14 | Upgrade
|
| Leasehold Improvements | 3.02 | 2.48 | 2.48 | 2.48 | 2.39 | 0.52 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.